Charles Schwab Investment Management Inc Guardant Health, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,277,099 shares of GH stock, worth $34.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,277,099
Previous 1,232,117
3.65%
Holding current value
$34.6 Million
Previous $33.3 Million
20.95%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding GH
# of Institutions
309Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$310 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$298 Million0.01% of portfolio
-
Baillie Gifford & CO6.23MShares$169 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$163 Million4.09% of portfolio
-
Cadian Capital Management, LP New York, NY5.79MShares$157 Million4.28% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.77B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...